Spyre Therapeutics (SYRE) Revenue (2015 - 2023)

Spyre Therapeutics (SYRE) posted Revenue of $688000.0 for Q2 2023, up 247.47% on a QoQ basis from $198000.0 in Q1 2023, and up 10.08% year-over-year from $625000.0 in Q2 2022.

Spyre Therapeutics (SYRE) Revenue (2015 - 2023) Analysis & Trends

Spyre Therapeutics' Revenue history runs 7 years deep, the most recent figure standing at $688000.0 for Q2 2023.

  • Quarterly Revenue rose 10.08% year-over-year to $688000.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $688000.0 (down 40.94% YoY) and the FY2023 annual result came in at $886000.0, down 61.96% from the prior year.
  • Revenue was $688000.0 for Q2 2023 at Spyre Therapeutics, up from $198000.0 in the prior quarter.
  • Across five years, Revenue topped out at $13.7 million in Q2 2021 and bottomed at $168000.0 in Q4 2022.
  • A 3-year average of $3.6 million and a median of $688000.0 in 2023 frame the typical range for Revenue.
  • Annual changes were most pronounced in 2022 — Revenue sank 98.55% — and 2023, when it climbed 10.08%.
  • Spyre Therapeutics' Revenue stood at $3.6 million in 2021, then tumbled by 95.39% to $168000.0 in 2022, then jumped by 309.52% to $688000.0 in 2023.
  • Business Quant data shows SYRE's Revenue at $688000.0 in Q2 2023, $198000.0 in Q1 2023, and $168000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.56 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Spyre Therapeutics 257.83 Mn 257.83 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 688,000.00
Mar 31, 2023 198,000.00
Dec 31, 2022 168,000.00
Sep 30, 2022 174,000.00
Jun 30, 2022 625,000.00
Mar 31, 2022 1.36 Mn
Dec 31, 2021 3.64 Mn
Sep 30, 2021 12.00 Mn
Jun 30, 2021 13.70 Mn
Jun 30, 2018 2.38 Mn
Mar 31, 2018 1.51 Mn
Dec 31, 2017 1.48 Mn
Sep 30, 2017 1.26 Mn
Jun 30, 2017 1.48 Mn
Mar 31, 2017 982,000.00
Dec 31, 2016 1.25 Mn
Sep 30, 2016 1.15 Mn
Jun 30, 2016 1.37 Mn
Mar 31, 2016 859,000.00
Dec 31, 2015 1.59 Mn